Compound Detail
CHEMBL301370
OPAVIRALINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL301370 |
| Name | OPAVIRALINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | KELNNWMENBUHNS-NSHDSACASA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
5
Known Names
Molecular Properties
280.3
MW (Da)
2.91
ALogP
3
HBA
1
HBD
58.6
PSA (Ų)
0.91
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Activity Summary
IC50 2 meas. best 7.35
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | IC50 | 7.35 | 7.05 | 45.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | IC50 | = | 45.0 | nM | 7.35 | Inhibition of HIV1 reverse transcriptase | 26708112 |
| Human immunodeficiency virus type 1 reverse transcriptase | IC50 | = | 179.0 | nM | 6.75 | Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase | 10937734 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11602674 | - | ATP-dependent translocase ABCB1 | 5 |
| 10937734 | 10.1016/s0960-894x(00)00321-8 | Human immunodeficiency virus type 1 reverse transcriptase | 2 |
| 26708112 | 10.1016/j.ejmech.2015.11.025 | Human immunodeficiency virus type 1 reverse transcriptase | 2 |
| 12086483 | 10.1021/jm010580q | Human immunodeficiency virus type 1 reverse transcriptase | 1 |
Data from ChEMBL 36 via Core Engine